Selective Sentinel Node Dissection in Melanoma with Trends and Future Directions

Area of Science:

• Oncology
• Surgical Oncology
• Immunology

Background:

• Melanoma historically shows a high tendency for metastasis to regional lymph nodes.
• Early aggressive surgical management of lymph nodes was controversial for decades.
• Sentinel lymph node (SLN) biopsy emerged as a minimally invasive alternative.

Purpose of the Study:

• To review the evolution and current controversies surrounding SLN biopsy in melanoma management.
• To highlight the diagnostic and potential therapeutic roles of SLN biopsy.
• To explore the utility of SLN in understanding melanoma biology and host-tumor interactions.

Main Methods:

• Review of prospective clinical trials evaluating SLN biopsy.
• Analysis of current controversies including patient selection and gene expression profiling.
• Exploration of SLN's role in melanoma immunology and potential therapeutic effects.

Main Results:

• SLN biopsy has clarified lymph node management in melanoma.
• Current debates focus on patient selection, gene expression profiling, and therapeutic implications.
• SLN provides valuable data on the host-tumor interface and immune microenvironment.

Conclusions:

• SLN biopsy represents a significant advancement in melanoma staging and management.
• Further research is needed to optimize patient selection and explore therapeutic benefits.
• SLN analysis offers insights into melanoma's biological mechanisms and immune interactions.